Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N05AH03	OLIZAX 5	G	Olanzapine - 5mg	5mg	Tablet, mouth dissolving	1,466,580 L.L
N05AH03	OLANZAMED	G	Olanzapine - 20mg	20mg	Tablet	3,941,938 L.L
A10BB12	ORBIDE	G	Glimepiride - 1mg	1mg	Tablet	207,336 L.L
G02AX	OXYTOCIN 10 PANPHARMA 10 UI-1ML	G	Oxytocin - 10IU/ml	10IU/ml	Injectable solution	525,442 L.L
G02AX	OXYTOCIN 10 PANPHARMA 10 UI-1ML	G	Oxytocin - 10IU/ml	10IU/ml	Injectable solution	525,442 L.L
N05AH03	OLANZAX 10	G	Olanzapine - 10mg	10mg	Tablet, mouth dissolving	2,329,327 L.L
N05AH03	OLIZAX 10	G	Olanzapine - 10mg	10mg	Tablet, mouth dissolving	2,598,096 L.L
A10BB12	ORBIDE	G	Glimepiride - 2mg	2mg	Tablet	209,895 L.L
J02AC01	ORAMAX	G	Fluconazole - 150mg	150mg	Capsule	170,668 L.L
C09DB02	OLMENOR COMBI	G	Olmesartan medoxomil - 20mg, Amlodipine - 5mg		Tablet, film coated	679,984 L.L
N05AH03	OLANZAMED	G	Olanzapine - 10mg	10mg	Tablet	902,294 L.L
C09DB02	OLMENOR COMBI	G	Olmesartan medoxomil - 40mg, Amlodipine - 5mg		Tablet, film coated	772,709 L.L
N05AH03	OLANZAPINE ARROW	G	Olanzapine - 10mg	10mg	Tablet	822,432 L.L
N05AH03	OLANZAPINE ARROW	G	Olanzapine - 7.5mg	7.5mg	Tablet	822,432 L.L
A10BB12	ORBIDE	G	Glimepiride - 3mg	3mg	Tablet	351,959 L.L
A10BB12	ORBIDE	G	Glimepiride - 4mg	4mg	Tablet	357,078 L.L
A04AA01	ONDAKEY	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	4,489,778 L.L
A04AA01	ONDANSETRON BIOGARAN	G	Ondansetron - 8mg	8mg	Tablet, coated	1,307,559 L.L
A04AA01	ONDANSETRON MEDIS	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	748,520 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	880,217 L.L
A04AA01	ONDANSETRON HIKMA	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	2,228,091 L.L
A04AA01	ONDANSETRON MEDIS	G	Ondansetron - 4mg/2ml	4mg/2ml	Injectable solution	978,317 L.L
A04AA01	ONDANSETRON RENAUDIN	G	Ondansetron (HCl dihydrate) - 4mg/2ml	4mg/2ml	Injectable solution	1,791,342 L.L
A10BD02	ORBIZIDE M FORTE	G	Metformin HCl - 500mg, Gliclazide - 80mg		Tablet	771,750 L.L
A04AA01	ONDANSETRON VIANEX	G	Ondansetron (HCl) - 4mg/2ml	4mg/2ml	Injectable solution	197,545 L.L
A04AA01	ODNATRON	G	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	952,784 L.L
A04AA01	ONDANSETRON HIKMA	G	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	4,018,089 L.L
A04AA01	ONDANSETRON MEDIS	G	Ondansetron - 8mg/4ml	8mg/4ml	Injectable solution	1,919,007 L.L
A04AA01	ONDANSETRON RENAUDIN	G	Ondansetron (HCl dihydrate) - 8mg/4ml	8mg/4ml	Injectable solution	2,433,699 L.L

...